Document Type

Article

Publication Date

6-2002

Publication Title

Technology in Cancer Research & Treatment

Volume

1

Issue

3

Pages

205-209

DOI

10.1177/153303460200100305

Abstract

Interferon α may be used as a single agent therapy for metastatic malignant melanoma or as an adjuvant to chemotherapy. Delivery of interferon α by gene therapy offers an alternative to recombinant protein therapy. Electrically mediated delivery enhances plasmid expression in a number of tissues, for instance skin, liver, muscle and tumors including melanomas. Here we compare the effect of delivery of a plasmid encoding mouse interferon α on growth of visible B16 mouse melanomas following electrically mediated delivery to muscle or directly to the tumor. Intratumoral delivery of interferon α plasmid not only slows melanoma growth, but induces complete, long term, regression. This effect was not observed after intramuscular delivery.

Original Publication Citation

Heller, L. C., Ingram, S. F., Lucas, M. L., Gilbert, R. A., & Heller, R. (2002). Effect of electrically mediated intratumor and intramuscular delivery of a plasmid encoding IFN α on visible B16 mouse melanomas. Technology in Cancer Research Treatment, 1(3), 205-209. doi:10.1177/153303460200100305

ORCID

0000-0001-8084-0787 (Heller, L.), 0000-0003-1899-3859 (Heller, R.)

Share

COinS